La Jolla Medical Transtortation is categorized under Health Services in Cathedral City, CA and active since 2010.
La Jolla Medical Transtortation was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Jesus Gomez at the company’s single location by writing to 34901 Marcia Road Apartment 4, Cathedral City, California CA 92234 or by phoning (760) 289-5064. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | La Jolla Medical Transtortation |
Contact Person: | Jesus Gomez |
Address: | 34901 Marcia Road Apartment 4, Cathedral City, California 92234 |
Phone Number: | (760) 289-5064 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Services |
SIC Code: | 8099 |
NAICS Code: | 621999 |
Share This Business: |
La Jolla Medical Transtortation was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jesus Gomez for inquiries that concern La Jolla Medical Transtortation by calling the company number (760) 289-5064, as your correspondence is most welcome. Additionally, the physical location of the single location of La Jolla Medical Transtortation can be found at the coordinates 33.794899,-116.454958 as well as the street address 34901 Marcia Road Apartment 4 in Cathedral City, California 92234.
For its online presence, you may visit La Jolla Medical Transtortation’s website at and engage with its social media outlets through on Twitter and on Facebook.